In vivo cleavage of protein S is a major determinant in thrombin generation and correlates with platelet count in individuals with hematological malignancies by Brinkman, H.J.M, Dienava-Verdoold, I, Marchetti, M.R, te Boome, L.C.J, Russo, L, Falanga, A, Koene, H.R, Mertens, K

Get full text

PCN85 - SAVING HEALTHCARE AND SOCIETAL COSTS BY CHANGING THE ROUTE OF ADMINISTRATION OF ONCOLOGY DRUGS by Franken, M.G., Kanters, T.A., Coenen, J.L., de Jong, P., Koene, H.R., Lugtenburg, P.J., Jager, A., Uyl-de Groot, C.A.

Get full text

Nutritional problems, nutritional support practices, and barriers to adherence to the espen/ebmt nutritional guidelines during intensive treatment for acute myeloid leukemia: patie... by van Lieshout, R., Lize, N., Tick, L.W., van Deursen, J., Driessen, E., Janssen, T., Custers, S., Kranenburg, S., van der Lee, D., Koene, H.R., Beckers, E.A., Schouten, H., Beijer, S.

Get full text

PROTEOMICS MARKERS PROGNOSTIC FOR OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER TREATMENT: RESULTS FROM THE HOVON‐109 STUDY by Straten, L., Hosnijeh, F., Straten, L., Kater, A.P., Oers, M.H., Posthuma, W.F., Chamuleau, M.E., Nijland, M., Hoogendoorn, M., De Croon, F., Wittebol, S., Kerst, J., Marijt, E.W., Raymakers, R.A., Koene, H.R., Dobber, J.A., Tonino, S.H., Kersting, S.S., Langerak, A.W., Levin, M.

Get full text

Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma by Geurts, Y.M., Neppelenbroek, S.I.M., Aleman, B.M.P., Janus, C.P.M., Krol, A.D.G., van Spronsen, D.J., Plattel, W.J., Roesink, J.M., Verschueren, K.M.S., Zijlstra, J.M., Koene, H.R., Nijziel, M.R., Schimmel, E.C., de Jongh, E., Ong, F., te Boome, L.C.J., van Rijn, R.S., Böhmer, L.H., Ta, B.D.P., Visser, H.P.J., Posthuma, E.F.M., Bilgin, Y.M., Muller, K., van Kampen, D., So-Osman, C., Vermaat, J.S.P., de Weijer, R.J., Kersten, M.J., van Leeuwen, F.E., Schaapveld, M.

Get full text

PO-71 In vivo cleavage of protein S is a major determinant in thrombin generation and correlates with platelet count in individuals with hematological malignancies by Brinkman, H.J.M., Dienava-Verdoold, I., Marchetti, M.R., te Boome, L.C.J., Russo, L., Falanga, A., Koene, H.R., Mertens, K.

Get full text

Prevalence of JAK2V617F mutation in women with unexplained recurrent miscarriage by KAANDORP, S. P., LAUW, M. N., VAN DER SCHOOT, C. E., GODDIJN, M., VAN DER VEEN, F., KOENE, H. R., BIEMOND, B. J., MIDDELDORP, S.

Get full text

PS1141 PROTEOMICS MARKERS PROGNOSTIC FOR OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER TREATMENT; RESULTS FROM THE HOVON‐109 STUDY by Hosnijeh, F. Saberi, Kater, A.P., Oers, M.H., Posthuma, W.F., Chamuleau, M.E., Nijland, M., Doorduijn, J.K., Gelder, M., Hoogendoorn, M., De Croon, F., Wittebol, S., Kerst, M., Marijt, E.W., Raymakers, R.A., Koene, H.R., Schaafsma, M.R., Dobber, J.A., Tonino, S.H., Kersting, S.S., Langerak, A.W., Levin, M.‐D.

Request full text

Soluble FcγRIII, a marker of the total body mass of neutrophils, correlates with disease severity in sepsis by Muller Kobold, A.C., Zijlstra, J.G., Koene, H.R., Kallenberg, C.G.M., Cohen Tervaert, J.W.

Get full text

Identifying predictive factors for vertebral collapse fractures in multiple myeloma patients by Zijlstra, Hester, Wolterbeek, Nienke, Drost, Rosalin W., Koene, Harry R., van der Woude, Henk Jan, Terpstra, Wim E., Delawi, Diyar, Kempen, Diederik H.R.

Get full text

The incidence of vertebral compression fractures and spinal instability in newly diagnosed multiple myeloma patients by Zijlstra, Hester, Wolterbeek, Nienke, Ponds, Noa H.M., Koene, Harry R., Terpstra, Wim E., Delawi, Diyar, Kempen, Diederik H.R.

Get full text